Literature DB >> 26694171

Bin1 Antibodies for IBD Therapy: Is Permeability the Answer BAR None?

George Kolios1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26694171     DOI： 10.1007/s10620-015-3997-x

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  11 in total

Review 1.  The value of experimental models of colitis in predicting efficacy of biological therapies for inflammatory bowel diseases.

Authors:  Vassilis Valatas; Michael Vakas; George Kolios
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-08-29       Impact factor: 4.052

2.  Identification of a novel effector domain of BIN1 for cancer suppression.

Authors:  Greta L Lundgaard; Natae E Daniels; Slovénie Pyndiah; Erica K Cassimere; Kazi M Ahmed; Amélie Rodrigue; Daisuke Kihara; Carol B Post; Daitoku Sakamuro
Journal:  J Cell Biochem       Date:  2011-10       Impact factor: 4.429

Review 3.  Inflammatory bowel disease: pathogenesis.

Authors:  Yi-Zhen Zhang; Yong-Yu Li
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

4.  Bin1 attenuation suppresses experimental colitis by enforcing intestinal barrier function.

Authors:  Mee Young Chang; Janette Boulden; M Carmen Valenzano; Alejandro P Soler; Alexander J Muller; James M Mullin; George C Prendergast
Journal:  Dig Dis Sci       Date:  2012-04-18       Impact factor: 3.199

5.  Novel Colitis Immunotherapy Targets Bin1 and Improves Colon Cell Barrier Function.

Authors:  Sunil Thomas; Joanna M Mercado; James DuHadaway; Kate DiGuilio; James M Mullin; George C Prendergast
Journal:  Dig Dis Sci       Date:  2015-07-21       Impact factor: 3.199

Review 6.  Treatment of IBD: where we are and where we are going.

Authors:  Charles N Bernstein
Journal:  Am J Gastroenterol       Date:  2014-12-09       Impact factor: 10.864

Review 7.  Biologic therapies in inflammatory bowel disease.

Authors:  Lawrence B Cohen; Radu M Nanau; Faustine Delzor; Manuela G Neuman
Journal:  Transl Res       Date:  2014-01-07       Impact factor: 7.012

Review 8.  Amphiphysin 2 (BIN1) in physiology and diseases.

Authors:  Ivana Prokic; Belinda S Cowling; Jocelyn Laporte
Journal:  J Mol Med (Berl)       Date:  2014-03-05       Impact factor: 4.599

9.  Bin1 ablation increases susceptibility to cancer during aging, particularly lung cancer.

Authors:  Mee Young Chang; Janette Boulden; Jessica B Katz; Liwei Wang; Thomas J Meyer; Alejandro Peralta Soler; Alexander J Muller; George C Prendergast
Journal:  Cancer Res       Date:  2007-08-15       Impact factor: 12.701

Review 10.  Altered permeability in inflammatory bowel disease: pathophysiology and clinical implications.

Authors:  Joachim Mankertz; Jörg-Dieter Schulzke
Journal:  Curr Opin Gastroenterol       Date:  2007-07       Impact factor: 3.287
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.